← EU GMP NON-COMPLIANCE
EU GMP NON-COMPLIANCE · SRI LANKA21 April 2026
Navesta Pharmaceuticals (Pvt) Ltd. — Statement of GMP Non-Compliance
Company
Navesta Pharmaceuticals (Pvt) Ltd.
Country
Sri Lanka
Report date
21 April 2026
Reference
MT/003NCR/2026
A statement of GMP non-compliance is the EU equivalent of an FDA Warning Letter: an EEA competent authority has found that a site does not comply with EU GMP. It can trigger recall, suspension of the manufacturing authorisation, or removal from the supply chain across the EEA.
READ THE FULL REPORT
The complete statement — the site, the inspecting authority, and the cited deficiencies — is published in the EudraGMDP database. SPEQ surfaces and indexes it for reference; the authoritative record lives on EudraGMDP.
View on EudraGMDP →DON’T BE THE NEXT REPORT
Non-compliance details are published by EU competent authorities in the EudraGMDP database; SPEQ surfaces them for reference and is not affiliated with or endorsed by the EMA or any national authority. The authoritative record is on EudraGMDP.